Skip to main content

Animations

MJFF Publications

7981 - 7990 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2018
  • 2024
  • 2021
  • 2022
  • 2016
  • 2022
  • 2020
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad192
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Dual role of USP 30 in controlling basal pexophagy and mitophagy
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201745595
    Citation Count: 153
  • Summary Details
    RESTRICTED
    Title: Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.4c00602
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab440
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-223190
    Citation Count: 14
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 212
  • Summary Details
    OPEN
    Title: Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acsami.2c14220
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27994
    Citation Count: 89
  • Summary Details
    RESTRICTED
    Title: Local Regulation of Striatal Dopamine Release Shifts from Predominantly Cholinergic in Mice to GABAergic in Macaques
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/jneurosci.1692-24.2025
    Citation Count: 0
  • Summary Details
    OPEN
    Title: An Inducible Luminescent System to Explore Parkinson’s Disease-Associated Genes
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25179493
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.